Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Avexa signs license agreement with MNLpharma for HIV integrase inhibitors

Feb. 14, 2006

Medivir designates candidate drug from HIV NNRTI program

Feb. 13, 2006

Fortovase discontinued, Invirase preferred option

Feb. 9, 2006

CSA-54 shows potent virucidal activity in in vitro tests against HIV

Feb. 8, 2006

CONRAD and Cellegy sign agreement for microbicide R&D

Feb. 3, 2006

Benitec delays IND filing for HIV/AIDS therapeutic

Feb. 2, 2006

Pharmexa begins phase I study for HIV vaccine candidates

Jan. 31, 2006

Therapeutic agents for HIV infection reported in recent patent literature

Jan. 24, 2006

Serono completes phase III trial of recombinant human growth hormone in HARS

Jan. 24, 2006

Continuous antiretroviral therapy found superior to episodic therapy

Jan. 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...